• Dosage of Resiatric in details
• Resiatric interactions
• Resiatric reviews

Dosage of Resiatric in details

Resiatric Dosage

Applies to the following strength(s): 0.25 mg; 0.1 mg

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

Usual Adult Dose for:

• Hypertension
• Schizophrenia
• Hyperthyroidism

Additional dosage information:

• Renal Dose Adjustments
• Liver Dose Adjustments
• Dose Adjustments
• Precautions
• Dialysis

Usual Adult Dose for Hypertension

Initial dose: 0.5 mg orally once a day for 1 to 2 weeks.

Maintenance dose: 0.1 to 0.25 mg orally once a day.

Usual Adult Dose for Schizophrenia

Initial dose: 0.5 mg orally once a day, but may range from 0.1 to 1 mg.

Maintenance dose: Adjust dose upward or downward according to patient response.

Usual Adult Dose for Hyperthyroidism

The value of orally administered Resiatric during thyrotoxic crisis is not known.

Limited data in which seven patients with thyrotoxic crisis received Resiatric 1 to 5 mg intramuscularly, then 0.07 to 0.3 mg per kg in the first 24 hours reveal significant, dose-related improvement in symptoms within four to eight hours of drug administration.

Renal Dose Adjustments

The elimination half-life of Resiatric may be significantly increased in patients with renal insufficiency, therefore Resiatric is not recommended in patients with renal dysfunction.

Liver Dose Adjustments

Data not available

Dose Adjustments

Full antihypertensive effects may take as long as 3 weeks to occur.

Precautions

Use higher doses cautiously because occurrence of serious mental depression and other side effects may increase considerably.

Dialysis

Resiatric is not dialyzable.

More about Resiatric

• Side Effects
• During Pregnancy or Breastfeeding
• Dosage Information
• Drug Images
• Drug Interactions
• Support Group
• En Espanol
• 3 Reviews - Add your own review/rating

Consumer resources

• Resiatric

Professional resources

• Resiatric (FDA)

Related treatment guides

• High Blood Pressure
• Hyperthyroidism
• Schizophrenia

What other drugs will affect Resiatric?

Do not take Resiatric if you are taking a monoamine oxidase inhibitor (MAOI) or if you have taken one in the last 14 days. MAOIs, used to treat depression, include isocarboxazid (Marplan), phenelzine (Nardil), and tranylcypromine (Parnate).

Before taking Resiatric, tell your doctor if you are taking any of the following medicines:

• a tricyclic antidepressant such as amitriptyline (Elavil, Endep), imipramine (Tofranil), doxepin (Sinequan), nortriptyline (Pamelor), and others;

• quinidine (Cardioquin); or

• digoxin (Lanoxin, Lanoxicaps).

You may require special monitoring or a dose adjustment if you are taking any of the medicines listed above.

Resiatric may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, antihistamines, sedatives (used to treat insomnia), pain relievers, anxiety medicines, and muscle relaxants. Tell your doctor about all medicines that you are taking, and do not take any medicine unless your doctor approves.

Drugs other than those listed here may also interact with Resiatric or affect your condition. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.

Resiatric interactions

MAO inhibitors should be avoided or used with extreme caution.

Concurrent use of tricyclic antidepressants may decrease the antihypertensive effect of Resiatric.

Concurrent use of Resiatric and direct-or-indirect acting sympathomimetics should be closely monitored. The action of direct-acting amines (epinephrine, isoproterenol, phenylephrine, metaraminol) may be prolonged when given to patients taking Resiatric. The action of indirect-acting amines (ephedrine, tyramine, amphetamines) is inhibited.

Resiatric should be used cautiously with digitalis and quinidine, since cardiac arrhythmias have occurred with rauwolfia preparations.

Concomitant use of Resiatric with other antihypertensive agents necessitates careful titration of dosage with each agent

References

1. DailyMed. "RESERPINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
2. FDA/SPL Indexing Data. "8B1QWR724A: The UNique Ingredient Identifier (UNII) is an alphanumeric substance identifier from the joint FDA/USP Substance Registration System (SRS).". https://www.fda.gov/ForIndustry/Data... (accessed September 17, 2018).
3. MeSH. "Antipsychotic Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Resiatric are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Resiatric. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reviews

There are no reviews yet. Be the first to write one!

Your name:  Email:  Spam protection:  < Type 17 here

Information checked by Dr. Sachin Kumar, MD Pharmacology